HSBC Holdings plc vs InMode Ltd — how do they compare? HSBC Holdings plc trades at $93 (market cap $311.92B), while InMode Ltd trades at $14.2 (market cap $809.93M). The key difference: HSBC Holdings plc is far larger — about 385.1× InMode Ltd's market cap, and HSBC Holdings plc pays a 4.05% dividend while InMode Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold HSBC Holdings plc for 36 Days and InMode Ltd for 28 Days on average.
| HSBC | INMD | |
|---|---|---|
Market Cap | $311.92B | $809.93M |
Volume | 3,546,658 | 365,490 |
Sector | Financials | Health |
52-Week High | $107.86 | $16.62 |
52-Week Low | $65.67 | $12.76 |
Typical Hold Time | 36 Days | 28 Days |
Enterprise Value | $222.19B | $313.27M |
Dividend Yield | 4.05% | — |
Signals from Pluang's Aura AI — not financial advice
HSBC trades at $92.96, down 0.8% with bearish technical indicators. The bank shows strong profitability with 34.54% net margin and 12.44% ROE, while trading at reasonable valuations (P/E 13.23). Recent earnings show mixed results with Q2 beat but Q1 miss. Analyst sentiment is mixed with 38.1% buy ratings amid strategic expansions in US wealth management and Asian markets.
HSBC presents a balanced opportunity with solid fundamentals offset by near-term technical weakness. Growth initiatives in wealth management and Asian markets provide upside potential, while CFO transition and European restructuring pose execution risks. The stock's valuation remains attractive relative to earnings power.
INMD trades at $14.20, up 1.36% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with 76.52% gross margins and 20.69% net income margin, though Q1 2026 earnings missed expectations. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share. Analyst consensus is divided with 45% buy ratings amid ongoing shareholder activism concerns.
The stock presents value opportunity with attractive valuation multiples (P/E 11.63, EV/EBITDA 4.48) but faces near-term execution risks. Key catalysts include Q3 earnings delivery and resolution of acquisition talks, while risks involve management credibility and competitive pressures in aesthetic medicine markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →